• Tue. Oct 26th, 2021

AstraZeneca, news Italy: second dose of vaccine, Lazio and leaflet


May 11, 2021

Vaccine AstraZeneca also for under 60 in Italy? The hypothesis appears, while Lazio announces open days for the over 40s. The drug, after reports of rare cases of thrombosis following administration, was recommended by the AIFA to subjects over the age of 60. The second dose is always given to those who have already received the first. Now, the parameters could change again and AstraZeneca could become available again in an ordinary way also for the under 60s. to extend the administration of this vaccine to the age group 50-60 years. “I would also open to the male population under 60, until the stocks are progressively exhausted”, said the Undersecretary of Health, Pierpaolo Sileri, on RaiNews24. “In February-March, I would not have put the restriction at 60, but I would have put it lower – he added – if we had expanded the audience in February we would have limited the damage among the elderly”.
AstraZeneca, authorized by the EMA for ages 18 and up, is currently recommended “preferentially” for the ‘over 60’ after the alarm following reports of rare thrombosis after the vaccine, especially among women under 40. The orientation of the CTS to widen the age range for the administration of this vaccine would be, according to what is learned, favorable, but nothing has yet been decided.In the meantime, Lazio announces that next weekend will be a long ‘open day’ AstraZeneca “with virtual ticket for the over 40s (born 1981)”, as announced by the Department of Health of the Region on the social portal ‘SaluteLazio’. “The dedicated administration hubs, the relative timetables and the platform for virtual tickets will be communicated in the coming days”, underlines the councilorship in reference to the appointments for Saturday 15 and Sunday 16 May. In Lazio it will also be possible to book the vaccine from the family doctor where, in addition to frail patients, even people over 40 years old can be vaccinated, but only with AstraZeneca and J&J, otherwise they will have to wait for the vaccination to open to their age group .BUGIARDINO The package leaflet of the vaccine, which recently changed its name and is now called Vaxzevria, has been updated after rare thrombosis cases in Europe. In the sheet on the Aifa website (here the Pdf), which indicates 18 years as the minimum age limit for administration, the paragraph ‘Blood disorders’ reads: “Very rare blood clots, often in unusual sites (for eg brain, intestines, liver, spleen), in association with low levels of blood platelets, in some cases accompanied by bleeding, have been observed after vaccination with Vaxzevria. This condition included severe cases with blood clots at different sites or as well as excessive clotting or bleeding throughout the body. Most of these cases occurred in the first fourteen days after vaccination and mainly occurred in women under 60 years of age. In some cases this condition resulted in death “. The section on ‘Possible side effects’ also reads:” Like all medicines, this vaccine can cause side effects, although not everybody gets them. If you notice any side effects not mentioned in this leaflet, please tell your doctor, pharmacist or nurse. Get urgent medical attention if symptoms of a severe allergic reaction occur. These reactions may include a combination of any of the following symptoms: – feeling faint or lightheaded – changes in heartbeat – shortness of breath – wheezing – swelling of the lips, face or throat – hives or rash – nausea or vomiting – stomach pain The following side effects may occur with Vaxzevria: Very common (may affect more than 1 in 10 people) – tenderness, pain, warmth, itching or bruising where the injection is given – feeling tired (fatigue) ) or feeling generally unwell – chills or feeling feverish – headache – feeling sick (nausea) – joint pain or muscle pain Common (may affect up to 1 in 10 people) – swelling or redness where it is used injection – fever (> 38 ° C) – being sick (vomiting) or diarrhea – low blood platelet levels Uncommon (may affect up to 1 in 100 people) – sleepiness or feeling dizzy – decreased appetite – swollen lymph nodes – excessive sweating, itching or rash Very rare (may affect up to 1 in 10,000 people) – blood clots often in unusual sites (eg. brain, intestine, liver, spleen), associated with low levels of platelets in the blood “.